文献速递质量管理与危急值临床生化

南非德班减少临床化学标本拒收的干预研究

Reducing sample rejection in Durban, South Africa.
PubMed 文献 · Clin Chem Lab Med · 2020-10-20

该研究测量2016年及2018年4月至2019年3月临床化学标本拒收率及原因,并在2018-2019干预期实施7项干预措施。总体拒收率从干预前的1.4%显著降至干预期的1.2%,拒收率≤1.2%的月份数从2个月显著增至6个月;不足、溶血和「过旧」标本显著减少,但不足标本仍是最常见拒收原因,2019年2月不足标本中三分之一来自新生儿单元、24%来自儿科单元。

要点

  • 7项干预措施可显著降低临床化学标本总体及月度拒收率。
  • 不足、溶血和「过旧」标本显著减少,但不足标本仍是最常见拒收原因。
  • 新生儿和儿科单元是标本不足的主要来源,应作为改进重点。

核心结论

  • 干预措施显著降低了总体拒收率和月度拒收率超标的月份数。
  • 不足、溶血和「过旧」标本显著减少,但不足标本仍是最常见拒收原因。
  • 一个月内大多数不足标本来自新生儿和儿科单元。

研究设计与样本

  • 研究测量2016日历年及2018年4月至2019年3月的标本拒收率及不同拒收原因的贡献。
  • 在2018-2019干预期实施7项干预措施以降低标本拒收。
  • 比较两个一年间期的拒收率、拒收率≤1.2%的月份数及拒收原因分布。
  • 确定第二期某一个月内因最常见拒收原因被拒收标本的来源。

主要发现

  • 总体拒收率从干预前的1.4%显著降至干预期的1.2%。
  • 拒收率在目标范围内的月份数从干预后的2个月显著增至干预期的6个月。
  • 不足、溶血和「过旧」标本显著减少,但不足标本仍是最常见拒收原因。
  • 2019年2月,所有不足标本中三分之一来自新生儿单元,24%来自儿科单元。

关键数值与推荐

  • 总体拒收率:干预前1.4%,干预期1.2%,差异显著。
  • 拒收率≤1.2%的月份数:干预后2个月,干预期6个月,差异显著。
  • 2019年2月不足标本来源:新生儿单元占三分之一,儿科单元占24%。

临床怎么用

  • 检验科可借鉴7项干预措施降低标本拒收率。
  • 应重点关注新生儿和儿科单元的标本采集质量以减少不足标本。
  • 持续监测拒收率及原因分布以评估干预效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rejections of clinical chemistry specimens delays the availability of results, which may impact patient management. The study aims to measure sample rejection rate, identify reasons for sample rejection, evaluate the effect of a campaign to reduce rejection rates and discover which clinical units produced the most insufficient specimen. METHODS: The study measured specimen rejection rates and the contributions of different rejection reasons in calendar 2016 and April 2018-March 2019. The study undertook a 7-intervention campaign to reduce specimen rejection during the 2018-2019 intervention period. It compared rejections rates, number of months with rejection rates ≤1.2%, and distribution of rejection reasons between the two year-long intervals. The study also determined the origin for specimens rejected for the most common rejection reason during one month in the second period. RESULTS: The overall rejection rate fell significantly from 1.4% in pre-intervention period to 1.2% in the intervention period. The number of months with rejection rates within the target range increased significantly from 2 in the post-intervention period to 6 in the intervention period. Insufficient, hemolysed, and 'too-old' specimen decreased significantly, however, insufficient specimen remained the most frequent rejection reason. In February 2019, one-third of all insufficient specimen came from neonatal units and 24% from the pediatric units. CONCLUSIONS: Interventions decreased significantly both overall and monthly rejection rates above target levels. Insufficient, hemolysed, 'too-old' specimen, became significantly less frequent, however, insufficient specimen remained the most frequent rejection reason. Over a month, most insufficient specimen came from neonatal and pediatric sites.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Magwai T, Warasally Z, Naidoo N, et al. Reducing sample rejection in Durban, South Africa. Clin Chem Lab Med. 2020. PMID: 33079694. doi:10.1515/cclm-2020-0827

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。